ABOUT POLARIS

Enabling next-generation oligonucleotide science

Polaris Oligonucleotides is a contract research organization dedicated to advance oligonucleotide science by offering cutting-edge, high quality custom synthetic services. With the current trend in oligonucleotide-based therapeutics going towards ever-increasing complexity, we focus our service offer on chemically modified oligonucleotides, oligoribonucleotides (RNA) and difficult/delicate syntheses, over a wide range of scales.

Owing to our team's synthetic experience, we can offer custom syntheses of both oligonucleotides and nucleosides monomers, giving our client's the ability to go beyond what is commercially available.
We built our business model on supporting oligonucleotides science innovations trough tailor-made synthetic strategies for each project evaluated. Why not join our fast growing customer base? Get in touch today to submit a project for evaluation or to learn more about the Polaris Oligonucléotides story!

Our Story

Polaris Oligonucleotides Inc. was founded in Laval (Québec, Canada) in 2022., with the head office located in Laval (Québec, Canada), and laboratories initially situated in Montreal.

Since then, we have moved to the CQIB (500 Boulevard Cartier W, Laval, QC H7V 5B7; Local 220), a state-of-the-art incubator in the heart of Laval's newly established biotech hub.

A privately owned company, our mission is to further oligonucleotide research by bringing innovative synthetic solutions, no matter the complexity of the project. We offer a wide range of services, from simple primers to complex therapeutic oligonucleotides. We are also strongly committed to supporting academic advancements in oligo science, as well as helping Canadian biotechs maintain their global competitiveness, by offering significant discounts for both Academics and Canadian-based biotechs.

Now offering DEL supplies (primers, tags, etc..)!